cisplatinum injection 10mg/ml
cisplatinum injection 10mg - injection - cisplatinum injection 10mg - cisplatin
cisplatinum injection 50mg/ml
cisplatinum injection 50mg - injection - cisplatinum injection 50mg - cisplatin
cisplatinum lyophilised
h.n. norton & company ltd - cisplatin - 10 milligram
cisplatinum lyophilised
h.n. norton & company ltd - cisplatin - 50 milligram
cisplatinum 50mg/100ml inj.
nippon kayaku-japan - injection - 0.5 mg
cisplatinum 50mg/100ml inj.
nippon kayaku-japan - injection - 0.5 mg
ebetaxel 6 mgml
novartis israel ltd - paclitaxel - concentrate for solution for infusion - paclitaxel 6 mg/ml - paclitaxel - paclitaxel - paclitaxel is indicated alone or in combination, for the treatment of advanced carcinoma of the ovary. for the treatment of metastatic breast cancer after failure of combination chemotherapy. prior therapy should have included an anthracycline unless clinically containdicated. paclitaxel is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. advanced non small cell lung cancer: paclitaxel associated with cisplatinum is indicated for the treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy. kaposis's sarcoma: paclitaxel is indicated in the second-line treatment of aids related kaposi's sarcoma
cisplatin cs 50mg in 50ml inj
pfizer (malaysia) sdn. bhd. - cisplatin/ cisplatinum -
dbl™ cisplatin injection 50mg50ml
hospira malaysia sdn bhd - cisplatin/ cisplatinum -
kemoplat injection 1mg/ml
fresenius kabi malaysia sdn. bhd - cisplatin/ cisplatinum -